Success factors in drug discovery and development
Journal: Advances in Precision Medicine (Vol.1, No. 2)Publication Date: 2016-12-31
Authors : Björn Wallmark;
Page : 1-5
Keywords : pharmaceutical industry; productivity factors;
Abstract
The article aimed to give a personal perspective on drug discovery and development. The author has worked both in Big Pharma as a scientist and manager and more recently also in start-up biotech companies. Drug companies have played a major important role in improving population health and will continue to do so. The hurdles and costs for drug development have continuously risen without a parallel enhancement of productivity. There is no single explanation for this and the article outlines success factors and hurdles for effective drug development. Aspects of the external and internal environments that influence Big Pharma productivity is outlined and discussed.
Other Latest Articles
- Reproducibility of preclinical data: one man's poison is another man's meat
- Precision medicine: do not neglect the hurdles
- What makes a good biomarker?
- Investigating the health-economic profiles of biomarker-driven immunosuppresion (BIO-DrIM) following solid organ transplantation
- Collaboration for success: the value of strategic col-laborations for precision medicine and biomarker discovery
Last modified: 2020-03-09 18:03:15